Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- European Medicines Agency (EMEA)

European Medicines Agency (EMEA) Newsletter

Purespring Therapeutics granted European Medicines Agency (EMA) orphan drug designation for PS-002 for the treatment of patients with primary IgA nephropathy (IgAN) 28 Apr 2025 06:00 GMT
… diseases, today announces that the European Medicines Agency (EMA) has granted orphan drug …
Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-251 in Duchenne Muscular Dystrophy 24 Apr 2025 11:30 GMT
- Recently presented data demonstrated sustained functional improvement with DYNE-251 treatment through 18 months - - Data from the fully enrolled DELIVER registrational expansion cohort is planned for late 2025 - WALTHAM, Mass., April 24, 2025 (GLOBE …
Madrigal to Present Late-Breaking Resmetirom Data in Patients with Compensated MASH Cirrhosis at the EASL Congress 29 Apr 2025 12:00 GMT
… is under evaluation with the European Medicines Agency’s (EMA) Committee for Medicinal …
Regeneron’s bispecific antibody Lynozyfic approved by EC to treat multiple myeloma 29 Apr 2025 11:43 GMT
… a recent recommendation from the European Medicines Agency’s human medicines committee and …
Takeda receives CHMP recommendation for Adcetris in Hodgkin lymphoma 29 Apr 2025 11:43 GMT
… a new recommendation from the European Medicines Agency’s human medicines committee for …
Prilenia and Ferrer to commercialise pridopidine in Europe 29 Apr 2025 10:15 GMT
… authorisation application (MAA) with the European Medicines Agency (EMA) for the approval of …
EMA grants orphan drug status to Purespring’s IgA nephropathy treatment 29 Apr 2025 10:33 GMT
The European Medicines Agency (EMA) has granted orphan drug …
Regeneron Treatment for Multiple Myeloma Gets Conditional Marketing Approval from EC 29 Apr 2025 11:13 GMT
… comes two months after the European Medicines Agency (EMA)’s Committee for Medicinal …
Biohaven secures $600m financing as it awaits FDA prodrug decision 29 Apr 2025 11:13 GMT
… uncertain. Earlier in April, the European Medicines Agency (EMA) questioned whether the drug …
BrainStorm's NurOwn® Data Selected as Breakthrough Science for Presentation at ISCT 2025 Meeting 29 Apr 2025 11:14 GMT
… Drug Administration (FDA) and the European Medicines Agency (EMA). A Phase 3 trial …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS